chromocell.com (CHRO) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Chromocell Therapeutics (CHRO) kompaniyasining ushbu kunlik narxlar grafigi asab tizimi terapiyasi yechimlarini ishlab chiqayotgan kompaniyaning faoliyatini aks ettiradi. Uning barqarorligi global logistika va savdo to'siqlarining yo'kligiga bog'liq, shu bilan birga separate_debt_long_eq ko'rsatkichi 0.00 darajasida turibdi. Zavod xarajatlaridan qochish uchun biznes dori vositalarini sintez qilish va sinovdan o'tkazishda tashqi pudratchilarga tayanadi, firma esa ekologik chiqindilarni yo'q qilishning asosiy standartlarini saqlab qoladi.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_CHRO_-_Chromocell-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "CHRO - Chromocell Therapeutics Corp. Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 02.07.2025 oraligʻida | 👁️GURU.Markets👁️")
Chromocell Therapeutics (CHRO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Chromocell Therapeutics|CHRO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati chromocell.com|CHRO - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Chromocell Therapeutics Corp.|CHRO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Chromocell Therapeutics|Shoshilinch likvidlik chromocell.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:Chromocell Therapeutics Corp - CHRO
Konservativ investor Chromocell Therapeutics (CHRO) kompaniyasining barqarorligini uning qarz yuklamasi prizmasi orqali baholaydi. R&D va FDA tasdiqlashiga tayanadigan biotexnologiya sektori uchun kredit riskini minimallashtirish juda muhimdir. Uzoq muddatli qarzning kapitalga nisbati aktivlar tarkibidagi muddati bir yildan ortiq bo'lgan majburiyatlarning ulushini o'lchaydi. Ushbu nisbatning kamayishi klinik sinovlar davridagi to'lov qobiliyatini tasdiqlaydi. Barqaror balans hisoboti yangi molekulalar ishlab chiqish davrida kompaniyaning omon qolishini ta'minlaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRAX|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Alector|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati Omeros Corp. OMER|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning o'z kapitaliga nisbati acimmune.com ACIU|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN: Uzoq muddatli qarzning o'z kapitaliga nisbati|alphacognition.com (ACOG) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CGTX (cogrx.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati IKT|SAVA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ASRT (Assertio Holdings, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati COYA|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga koeffitsiyenti OVID|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati CervoMed, Inc.|alteritytherapeutics.com (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Clene - Uzoq muddatli qarzning kapitalga koeffitsiyenti|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|Firefly Neuro (AIFF) - Uzoq muddatli majburiyatlarning kapitalga nisbati|KLTO: Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN - Uzoq muddatli qarzning kapitalga nisbati|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli kreditlarning kapitalga nisbati|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Helius Medical Technologies Inc. (HSDT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati PASG|Uzoq muddatli qarzning o'z kapitaliga nisbati bionomics.com.au NEUP|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|Uzoq muddatli qarzdorlikning kapitalga nisbati Athira Pharma Inc (ATHA)|Addex Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Alzamend Neuro, Inc. (ALZN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN: Uzoq muddatli qarzning kapitalga nisbati|Protagenic Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp|CRGT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc (ATXI)|BCLI - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cara Therapeutics, Inc. CARA|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|MRNS (Marinus) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp (NKGN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati